News & Analysis as of

Pharmaceutical Industry › South Africa

Proskauer - Life Sciences

Artificial Intelligence as the Inventor of Life Sciences Patents?

Proskauer - Life Sciences on

The question whether an artificial intelligence (“AI”) system can be named as an inventor in a patent application has obvious implications for the life science community, where AI’s presence is now well established and...more

Hogan Lovells

COVID-19 block exemption for the healthcare sector - South Africa

Hogan Lovells on

Acting swiftly to try to contain the spread of Covid-19 in South Africa, on 15 March 2020 President Cyril Ramaphosa declared a National State of Disaster. Now the government has gone further - on 19 March 2020 regulations...more

Hogan Lovells

Complementary Medicines: the way forward

Hogan Lovells on

According to a recent report published by Grand View Research, Inc., it is expected that by 2026, the global complementary and alternative medicine (CAM) industry will generate over USD 200 billion. The CAM industry, which...more

Hogan Lovells

The South African pharmaceutical regulatory environment

Hogan Lovells on

Our local pharmaceutical environment is highly regulated.The most important legislative provisions are found in the Medicines Act and the Pharmacy Act....more

Hogan Lovells

The evolution of CBD in South Africa

Hogan Lovells on

During the past several decades, the advances made in the life sciences and health care industries have been astounding, not to mention revolutionary. A presently obscure and experimental treatment may, in a day or week or...more

Hogan Lovells

Draft Fee Regulations – Attempts to Address Incentivising Loopholes

Hogan Lovells on

Section 18A of the South African Medicines Act (the “Medicines Act“) prohibits the supply of any medicine, medical device or in-vitro diagnostic device, according to a bonus system, rebate system or any other incentive...more

Hogan Lovells

Substantial Changes to South Africa’s Medical Device Regulations Have Far-Reaching Impacts

Hogan Lovells on

Although medicines have always been heavily regulated in South Africa, medical devices have not. Recently, however, Medical Device Regulations have been issued to bring medical devices into the regulatory fold. Medical...more

Hogan Lovells

Medical devices – South Africa's changing landscape

Hogan Lovells on

Subject to certain exceptions, medical devices have historically not been heavily regulated in South Africa.  Prescriptive requirements for medical devices were not in force and advertisers and marketers of medical devices...more

Patterson Belknap Webb & Tyler LLP

Global Inquiries into Drug Price Increases

Patterson Belknap Webb & Tyler LLP on

European competition authorities announced this week an investigation into Aspen Pharmacare’s recent price hikes of five cancer drugs. The European Commission said in a press release that it had “information indicating that...more

WilmerHale

Freedom to Utilize Genetic Resources? The Nagoya Protocol Two Years Later

WilmerHale on

Two years ago today, the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits from their Utilization to the Convention on Biological Diversity (“Protocol”) entered into international...more

Goodwin

Cipla to Open Biotech Facility in South Africa

Goodwin on

Cipla has announced that it is investing 1.3 billion South African Rand (approximately 91 million USD) to open a biotech plant in South Africa. According to Cipla’s press release, this will be South Africa’s first...more

11 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide